Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/17/2015 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Pierre-Yves Desprez?

Pierre-Yves Desprez

Cancer Research

CPMCRI Currents

HQ Phone:  (415) 600-3688

Email: p***@***.org

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

CPMCRI Currents

2200 Webster Street 5Th Floor

San Francisco, California,94115

United States

Background Information

Employment History

Cancer Researcher

California Pacific Medical Center


Principal Investigator

Cancer Research Institute


Affiliations

Sutter Health

Board Member


Education

Ph.D

California Pacific Medical Center Research Institute


Ph.D.

University of Lyon


Web References(56 Total References)


Cancer Research | Dr. Pierre-Yves Desprez | CPMCRI-currents

www.cpmcri-currents.org [cached]

Pierre-Yves Desprez, Ph.D.
Cancer Research | Dr. Pierre-Yves Desprez | CPMCRI-currents Home>Our People>Discovery Investigators>Desprez Lab> Pierre-Yves Desprez, Ph.D. Pierre-Yves Desprez, Ph.D., Senior Scientist Liliana Soroceanu, Sean McAllister and Pierre-Yves Desprez, in Cancer Research 2013 and showing the effects of targeting Id-1 (either by genetic knockdown or by using a cannabinoid compound) on the behavior of aggressive cancer cells. Dr. Desprez and his colleagues found that Id genes and proteins not only correlate with but also determine the level of aggressiveness of human breast and prostate cancer cells, and that Id-1 regulates multiple tumor-promoting pathways in brain cancer (glioblastoma). In collaboration with CPMCRI scientist Dr. Sean McAllister, recent investigations by Dr. Desprez have determined that cannabidiol (CBD), a cannabinoid with a low toxicity profile, inhibits human cancer cell proliferation and invasion through differential modulation of specific pathways, and down-regulates Id-1 gene expression. Dr. Desprez is among a group of investigators leading cancer research at CPMCRI. Training Before joining CPMCRI, Dr. Desprez completed his Ph.D. at the University of Lyon in France, and worked as a postdoctoral fellow in the laboratories of Drs. Pierre-Yves Desprez, Ph.D., Senior Scientist Primary Research Interests Pierre-Yves Desprez, Ph.D.


Our People: California Pacific Medical Research Institute

www.cpmcri-currents.org [cached]

Pierre-Yves Desprez, Ph.D.


News Box

www.cpmc.org [cached]

"We found high levels of expression of the Id-1 gene in breast tumor biopsies from patients with aggressive cancer," says Dr. Pierre-Yves Desprez of CPMCRI, the leading author of this study."But up until now, we didn't know if it could also function as a potential gene therapy target for suppressing metastasis in humans.Our pre-clinical study with mice confirms that Id-1 gene therapy suppresses the spread of cancer and blocks metastasis," Dr. Desprez says. What does this mean for human cancer patients?According to Dr. Desprez, "as soon as the same methodology is applicable to humans, Id-1 gene could represent a highly promising target for breast cancer patients with invasive and metastatic cancer.Metastasis is what kills patients, not the primary tumor."The study published in PNAS was a "bench to bedside" project done entirely at California Pacific Medical Center and primarily funded by the National Cancer Institute and the California Breast Cancer Research Program.It represents the endpoint of several years of collaboration among basic scientists (Drs. Nancy M. Lee, Robert J. Debs, and Pierre-Yves Desprez) and clinicians/pathologists (Drs. Peter C. Richards and James L. Bennington).More Id-1 would mean a bad prognosis for breast cancer patients and therefore more aggressive treatment to prevent the spread of the disease," said Dr. Desprez.


California Pacific Medical Center - Research

www.cpmc.org [cached]

Pierre Desprez, PhD Research Seminars415-600-1760 Email: DesprePY@cpmcri.org


Marijuana freeze cancer cells and prevents them from spreading

dafuqfacts.com [cached]

Pierre Desprez is a molecular biologist (one of the scientists behind this discovery) he spent decades studying (ID-1), the gene that cause cancer to spread in our body.
Pierre Desprez said - "It took us about 20 years of research to figure this out, but now we are very excited. We want to get started with trials as soon as possible." "We started by researching breast cancer," said Desprez. While marijuana advocates will surely praise the discovery, Desprez explained that it's not so easy as just lighting up. "We used injections in the animal testing and are also testing pills," he said. "But you could never get enough Cannabidiol for it to be effective just from smoking." Furthermore, the team has started synthesizing the compound in the lab instead of using the plant in an effort to make it more potent. "It's a common practice," explained Desprez.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory